The matrix Selleckchem BAY 73-4506 components are complex numbers; ϵ 0 directed in direction is a pure imaginary number and directed in is a real number. Voltage pulse on site This interaction can be applied as a gate voltage inside the QD. In order to modify the electrostatic potential, we use a square

pulse of width τ v and magnitude V g0. The Hamiltonian is (4) (5) The matrix components in Equation 5 are diagonal, so this interaction only modifies the energies on the site. Since the Heaviside function θ depends on r in Equation 4, the matrix components are the probability to be inside the quantum dot which is different www.selleckchem.com/products/i-bet151-gsk1210151a.html for each eigenstate, so this difference can introduce relative phases inside the qubit subspace. One-qubit quantum logic gates Therefore, we have to solve the dynamics of QD problem in N-dimensional states involved, where the control has to minimize the probability of leaking to states out of the qubit subspace in order to approximate the dynamic to the ideal state to implement correctly the one-qubit gates. The total Hamiltonian for both quantum dot and time-dependent interactions is , where is the quantum dot part (Equation 1) and V laser(t) and V gate(t) are the time control

interactions given by Equations 3 and 4. We expand the time-dependent solution in terms of the QD states (Equation 2) as. Therefore, the equations for the evolution of probability of being in state l at time t, C l (t), {Selleck Anti-diabetic Compound Library|Selleck Antidiabetic Compound Library|Selleck Anti-diabetic Compound Library|Selleck Antidiabetic Compound Library|Selleckchem Anti-diabetic Compound Library|Selleckchem Antidiabetic Compound Library|Selleckchem Anti-diabetic Compound Library|Selleckchem Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|Anti-diabetic Compound Library|Antidiabetic Compound Library|buy Anti-diabetic Compound Library|Anti-diabetic Compound Library ic50|Anti-diabetic Compound Library price|Anti-diabetic Compound Library cost|Anti-diabetic Compound Library solubility dmso|Anti-diabetic Compound Library purchase|Anti-diabetic Compound Library manufacturer|Anti-diabetic Compound Library research buy|Anti-diabetic Compound Library order|Anti-diabetic Compound Library mouse|Anti-diabetic Compound Library chemical structure|Anti-diabetic Compound Library mw|Anti-diabetic Compound Library molecular weight|Anti-diabetic Compound Library datasheet|Anti-diabetic Compound Library supplier|Anti-diabetic Compound Library in vitro|Anti-diabetic Compound Library cell line|Anti-diabetic Compound Library concentration|Anti-diabetic Compound Library nmr|Anti-diabetic Compound Library in vivo|Anti-diabetic Compound Library clinical trial|Anti-diabetic Compound Library cell assay|Anti-diabetic Compound Library screening|Anti-diabetic Compound Library high throughput|buy Antidiabetic Compound Library|Antidiabetic Compound Library ic50|Antidiabetic Compound Library price|Antidiabetic Compound Library cost|Antidiabetic Compound Library solubility dmso|Antidiabetic Compound Library purchase|Antidiabetic Compound Library manufacturer|Antidiabetic Compound Library research buy|Antidiabetic Compound Library order|Antidiabetic Compound Library chemical structure|Antidiabetic Compound Library datasheet|Antidiabetic Compound Library supplier|Antidiabetic Compound Library in vitro|Antidiabetic Compound Library cell line|Antidiabetic Compound Library concentration|Antidiabetic Compound Library clinical trial|Antidiabetic Compound Library cell assay|Antidiabetic Compound Library screening|Antidiabetic Compound Library high throughput|Anti-diabetic Compound high throughput screening| in the interaction picture, are given by: (6) The control problem of how to produce the gates becomes a dynamic optimization one, where we have to find the combination of the interaction parameters that produces the one-qubit gates (Pauli matrices). We solve it using a genetic algorithm [8] which allows us to avoid local

maxima and converges in a short time over a multidimensional space (four control parameters in our case). The steps in the GA approach are presented in Figure 2, where the key elements that we require to define four our problem are chromosomes and fitness. In our model, the chromosomes in GA are the array of values 1, where V g0 is the voltage pulse magnitude, τ v is the voltage pulse width, ϵ 0 is the electric field magnitude, and ρ is the electric field direction. The fitness function, as a measure of the gate fidelity, is a real number from 0 to 1 that we define as fitness(t med) = | < Ψ obj|Ψ(t med) > |2 × | < Ψ0|Ψ(2t med) > |2 where |Ψobj 〉 is the objective or ideal vector state, which is product of the gate operation (Pauli matrix) on the initial state |Ψ 0〉. Then, we evolve the dynamics to the measurement time t med to obtain |Ψ(t med)〉. Determination of gate fidelity results in the probability to be in the objective vector state at t med.